Literature DB >> 349386

Asymptomatic structural liver disease in hemophilia.

J A Spero, J H Lewis, D H Van Theil, U Hasiba, B S Rabin.   

Abstract

In a study of persistent abnormalities of liver-function tests in hemophilic patients deficient in factor VIII or IX and treated with factor VIII or IX concentrates, we examined 14 liver biopsies from 13 anti-HBs-positive patients. None had any symptoms of liver disease. All had chronically abnormal levels of alanine aminotransferase. Histologic studies showed chronic persistent hepatitis in eight patients, chronic active hepatitis in four and fatty infiltration with portal fibrosis in one. Indirect immunofluorescence of antiserums containing anti-HBs or anti-HBc (or both) revealed nuclear and cytoplasmic fluorescence in the hepatocytes of eight of 12 patients. Specificity testing of these antiserums confirmed that hepatitis B viral markers are present in the hepatocytes of these anti-HBs-positive patients. These histologic derangements are probably related to frequent treatment with blood products obtained from multiple donors and to the persistance of hepatitis B virus in hepatocytes despite the presence of circulating anti-HBs.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 349386     DOI: 10.1056/NEJM197806222982501

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  21 in total

1.  Impact of HIV on liver fibrosis in men with hepatitis C infection and haemophilia.

Authors:  M V Ragni; C G Moore; K Soadwa; M A Nalesnik; A B Zajko; A Cortese-Hassett; T L Whiteside; S Hart; A Zeevi; J Li; O S Shaikh
Journal:  Haemophilia       Date:  2010-08-16       Impact factor: 4.287

2.  Effect of human immunodeficiency virus infection on hepatitis C virus infection in hemophiliacs.

Authors:  M G Ghany; C Leissinger; R Lagier; R Sanchez-Pescador; A S Lok
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

Review 3.  Hemophilia treatment in historical perspective: a review of medical and social developments.

Authors:  F R Rosendaal; C Smit; E Briët
Journal:  Ann Hematol       Date:  1991-02       Impact factor: 3.673

Review 4.  Hepatitis C virus and transfusion transmitted liver disease: review.

Authors:  J C Underwood
Journal:  J Clin Pathol       Date:  1990-06       Impact factor: 3.411

Review 5.  Progressive change in lymphocyte distribution and degree of hypergammaglobulinemia with age in children with hemophilia.

Authors:  B T Shannon; J Roach; M Cheek-Luten; C Orosz; F B Ruymann
Journal:  J Clin Immunol       Date:  1986-03       Impact factor: 8.317

6.  Abnormal B cell function in haemophiliacs and their relationship with factor concentrates administration.

Authors:  J A Brieva; J Sequi; J M Zabay; A Pardo; A Campos; M Luz de la Sen; A Bootello
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

7.  [Frequency of hepatitis B virus markers and antibodies to rubella viruses in patients with lymphoproliferative disorders (author's transl)].

Authors:  T Sauerbruch; G Frösner; H Theml; K Eggert; H Kaess
Journal:  Blut       Date:  1980-04

8.  Bleeding after liver biopsy.

Authors:  A S Mahal; C M Knauer; P B Gregory
Journal:  West J Med       Date:  1981-01

9.  Chronic liver disease in transfusion-dependent thalassaemia: hepatitis B virus marker studies.

Authors:  S De Virgiliis; G Fiorelli; S Fargion; G Cornacchia; G Sanna; P Cossu; V Murgia; A Cao
Journal:  J Clin Pathol       Date:  1980-10       Impact factor: 3.411

10.  Liver disease complicating severe haemophilia in childhood.

Authors:  K M McGrath; J S Lilleyman; D R Triger; J C Underwood
Journal:  Arch Dis Child       Date:  1980-07       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.